Retinoic acid mediates long-paced oscillationsin retinoid receptor activity: Evidence for a potential role for RIP140

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Heim, Kelly C ^a   Gamsby, Joshua J ^b   Hever, Mary P ^a   Freemantle, Sarah J ^a   Loros, Jennifer J ^b   Dunlap, Jay C ^b   Spinella, Michael J ^a,c  

^a Department of Pharmacology and Toxicology ^*  (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; NUCLEAR RECEPTOR COREPRESSOR; NUCLEAR RECEPTOR COREPRESSOR 1; RECEPTOR INTERACTING PROTEIN 140; RETINOIC ACID; RETINOIC ACID RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA5; UNCLASSIFIED DRUG; CELL RECEPTOR; HOMEODOMAIN PROTEIN; HOXA5 PROTEIN, HUMAN; HOXA5 PROTEIN, MOUSE; NUCLEAR PROTEIN; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSCILLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; ANIMAL; BIOLOGICAL MODEL; CELL LINE; CELL STRAIN 3T3; GENE EXPRESSION REGULATION; METABOLISM; OSCILLOMETRY; PHYSIOLOGY; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; MICE; MODELS, BIOLOGICAL; NIH 3T3 CELLS; NUCLEAR PROTEINS; OSCILLOMETRY; PHOSPHOPROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; TRETINOIN;

EID: 70449602437     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007639     Document Type: Article

References (50)

1. Niles RM (2004) Signaling pathways in retinoid chemoprevention and treatment of cancer. Mutat Res 555: 81-96.
2. Freemantle SJ, Spinella MJ, Dmitrovsky E (2003) Retinoids in cancer therapy and prevention: Promise meets resistance. Oncogene 22: 7305-7315.
3. Buletic Z, Soprano KJ, Soprano DR (2006) Retinoid targets for the treatment of cancer. Crit Rev Eukaryot Gene Exp 16: 193-210.
4. Mark M, Ghyselinck NB, Chambon P (2009) Function of retinoic acid receptors during embryonic development. Nucl Recept Signal 7: e002.
5. Perissi V, Rosenfeld MG (2005) Controlling nuclear receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol 7: 542-54.
6. White RW, Morganstein D, Christian M, Seth A, Herzog B, et al. (2008) Role of RIP140 in metabolic tissues: Connections to disease. FEBS Let 582: 39-45.
7. Gurevich I, Flores AM, Aneskievich BJ (2007) Corepressors of agonist-bound nuclear receptors. Toxicol Appl Pharmacol 223: 288-298.
8. Wei LN, Hu X, Chandra D, Seto E, Farooqui M (2000) Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. J Biol Chem 275: 40782-40787.
9. Vo N, Field C, Goodman RH (2001) Acetylation of nuclear hormone receptorinteracting protein RIP140 regulates binding of the transcriptional corepressor CtBP. Mol Cell Biol 21: 6181-6188.
10. Kerley JS, Olsen SL, Freemantle SJ, Spinella MJ (2001) Transcriptional activation of the nuclear receptor corepressor RIP140 by retinoic acid: A potential negative-feedback regulatory mechanism. Biochem Biophys Res Commun 285: 969-975.
11. White KA, Yore MM, Warburton SL, Vaseva AV, Rieder E, et al. (2003) Negative feedback at the level of nuclear receptor coregulation: self-limitation of retinoid signaling by RIP140. J Biol Chem 278: 43889-43892.
12. Heim KC, White KA, Deng D, Tomlinson CR, Moore JH, et al. (2007) Selective repression of retinoic acid target genes by RIP140 during induced tumor cell differentiation of pluripotent human embryonal carcinoma cells. Mol Cancer 19: 57.
13. Aoyagi S, Archer TK (2009) Dynamics of coactivator recruitment and chromatin modifications during nuclear receptor mediated transcription. Mol Cell Endocrinol 280: 1-5.
14. Gamsby JJ, Loros JJ, Dunlap JC (2009) A phylogenetically conserved DNA damage response resets the circadian clock. J Biol Rhythms 24: 193-202.
15. Loots G, Ovcharenko I (2007) ECRbase: database of evolutionary conserved regions, promoters, and transcription factor binding sites in vertebrate genomes. Bioinformatics 23: 122-124.
16. Lee CH, Wei LN (1999) Characterization of receptor-interacting protein 140 in retinoid receptor activities. J Biol Chem 274: 31320-31326.
17. Shang YF, Hu X, DiRenzo J, Lazar MA, Brown M (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103: 843-852.
18. Metivier R, Penot G, Hubner MR, Reid G, Brand H, et al. Estrogen receptoralpha directs ordered, cyclic, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115: 751-763.
19. Metivier R, Gallais R, Tiffoche C, Le Peron C, Jurkowska RZ, et al. (2008) Cyclical DNA methylation of a transcriptionally active promoter. Nature 452: 45-50.
20. Lahav G (2008) Oscillations by the p53-Mdm2 feedback loop. Adv Exp Med Biol 641: 28-38.
21. Teboul M, Guillaumond F, Grechez-Cassiau A, Delaunay F (2008) The nuclear hormone receptor family round the clock. Mol Endocrinol 22: 2573-2582.
22. Liu X, Sempere LF, Galimberti F, Freemantle SJ, Black C, et al. (2009) Uncovering growth-suppressive MicroRNAs in lung cancer. Clin Cancer Res 15: 1177-1183.
23. Lin R, Nagai Y, Sladek R, Bastien Y, Ho J, et al. (2002) Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol Endocrinol 16: 1243-1277.
24. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, et al. (2003) Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinol 144: . pp 4562-4574.
25. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, et al. (2006) Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38: 1289-1297.
26. Augereau P, Badia E, Fuentes M, Rabenoelina F, Corniou M, et al. (2006) Transcriptional regulation of the human NRIP/RIP140 gene by estrogen is modulating by dioxin signaling. Mol Pharmacol 69: 1338-1346.
27. Carascossa S, Gobinet J, Georget V, Lucas A, Badia E, et al. (2006) Receptorinteracting protein 140 is a repressor of the androgen receptor activity. Mol Endocrinol 20: 1506-1518.
28. Nichol D, Christian M, Steel JH, White R, Parker MG (2006) RIP140 expression is stimulated by estrogen-related receptor alpha during adipogenesis. J Biol Chem 281: 32140-32147.
29. Augereau P, Badia E, Balaguer P, Carascossa S, Castet A, et al. (2006) Negative regulation of hormone signaling by RIP140. J Steroid Biochem Mol Biol 102: 51-59.
30. Subramaniam N, Treuter E, Okret S (1999) Receptor interacting protein RIP140 inhibits both positive and negative gene regulation by glucocorticoids. J Biol Chem 274: 18121-18127.
31. Treuter E, Albrektsen T, Johansson L, Leers J, Gustafsson JA (1998) A regulatory role for RIP140 in nuclear receptor activation. Mol Endocrinol 12: 864-881.
32. Tsai TY, Choi YS, Ma W, Pomerening JR, Tang C, et al. (2008) Robust, tunable biological oscillations from interlinked positive and negative feedback loops. Science 231: 126-129.
33. Tigges M, Marquez-Lago TT, Stelling J, Fussenegger M (2009) A tunable synthetic mammalian oscillator. Nature 457: 309-312.
34. Nagaich AK, Walker DA, Wolford R, Hager GL (2004) Rapid periodic binding and displacement of the glucicorticoid receptor during chromatin remodeling. Mol Cell 14: 163-174.
35. Kang Z, Pirskanen A, Janne OA, Palvimo JJ (2002) Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J Biol Chem 277: 48366-48371.
36. Wu RC, Feng Q, Lonard DM, O'Malley BW (2007) SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock. Cell 129: 1125-1140.
37. Kim S, Shevde NK, Pike JW (2005) 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, coactivator recruitment, and histone acetylation in intact osteoblasts. J Bone Miner Res 20: 305-317.
38. Reid G, Hubner MR, Metivier R, Brand H, Denger S, et al. (2003) Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11: 695-707.
39. Wang Q, Carroll J S, Brown M (2005) Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell 19: 631-642.
40. Debevec D, Christian M, Morganstein D, Seth A, Herzog B, et al. (2007) Receptor interacting protein 140 regulates expression of uncoupling protein 1 in adipocytes through specific peroxisome proliferator activated receptor isoforms and estrogen-related receptor alpha. Mol Endocrinol 21: 1581-1592.
41. Sonoda J, Pei L, Evans RM (2008) Nuclear receptors: decoding metabolic disease. FEBS Lett 582: 2-9.
42. Seth A, Steel JH, Nichol D, Pocock V, Kumaran MK, et al. (2007) The transcriptional corepressor RIP140 regulates oxidative metabolism in skeletal muscle. Cell Metab 6: 236-245.
43. Herzog B, Hallberg M, Seth A, Woods A, White R, et al. (2007) The nuclear receptor cofactor, receptor-interacting protein 140, is required for the regulation of hepatic lipid and glucose metabolism by liver X receptor. Mol Endocrinol 21: 2687-2697.
44. Powelka AM, Seth A, Virbasius JV, Kiskinis E, Nicoloro SM, et al. (2006) Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J Clin Invest 116: 125-136.
45. Leonardsson G, Steel JH, Christian M, Pocock V, Milligan S, et al. (2004) Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc Natl Acad Sci U S A 101: 8437-8442.
46. Huq M, Gupta P, Wei LN (2008) Post-translational modifications of nuclear corepressor RIP140: A therapeutic target for metabolic diseases. Curr Med Chem 15: 386-392.
47. de Thé H, Vivanco-Ruiz MM, Tiollais P, Stunnenberg H, Dejean A (1990) Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 343: 177-180.
48. Leroy P, Nakshatri H, Chambon P (1991) Mouse retinoic acid receptor alpha isoform is transcribed from a promoter that contains a retinoic acid response element. Proc Natl Acad Sci U S A 88: 10138-10142.
49. Chen Y, Hu X, Wei, LN (2004) Molecular interaction of retinoic acid receptors with coregulators PCAF and RIP140. Mol Cell Endocrinol 226: 43-50.
50. Hu X, Chen Y, Farooqui M, Thomas MC, Chiang CM, et al (2004) Suppressive effects of receptor-interaction protein 140 on coregulator binding to retinoic acid receptor complexes, histone modifying enzyme activity, and gene activation. J Biol Chem 279: 319-325.